ArticlePloS one2026

Inhibition of HER2 signaling and breast cancer cell growth with a novel antibody targeting HER2 ECD III/IV.

Chunchun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.